Relegs offers a CE‑marked, wireless TENS system that delivers targeted electrical stimulation to the calf to alleviate Restless Legs Syndrome symptoms. The battery‑powered device uses reusable self‑adhesive electrode patches and a one‑button interface, enabling patients to treat episodes at home, work, or while traveling without additional medication. It is sold directly to consumers for €399.95, with optional accessories for ongoing use.
Funding
Funding not disclosed
Founders
Product
Problem
Restless Legs Syndrome (RLS) causes involuntary leg sensations that disrupt sitting and sleep, and many patients rely on medication despite side‑effects or limited efficacy. Non‑pharmacological options that are portable, easy to use, and clinically validated are scarce.
Solution
Relegs provides a compact, wireless transcutaneous electrical nerve stimulation (TENS) system that delivers targeted electrical pulses to the calf to activate nerves and muscles, reducing RLS symptoms. The device is CE‑certified, battery‑operated, and can be applied independently of a clinical setting, allowing users to treat episodes at home, during travel, or at work. It includes reusable self‑adhesive electrode patches and a dedicated charger, enabling daily use without recurring consumable costs. The system is designed to complement existing pharmacological treatments, offering an additional therapeutic pathway for patients who need symptom relief without increasing medication load. A user‑friendly interface and instructional videos guide proper placement and operation, ensuring consistent therapeutic delivery. All components meet European medical‑device regulations, providing a safe, regulated alternative for RLS management.
Target Audience
The primary customers are adults (18–90 years) diagnosed with Restless Legs Syndrome who seek a non‑pharmacological, at‑home treatment, as well as healthcare providers recommending adjunctive therapy for RLS patients.
Features
- CE‑marked, wireless TENS stimulator housed in a lightweight plastic casing for discreet, on‑the‑go use
- Targeted electrical stimulation applied to the calf via reusable self‑adhesive electrode patches
- Battery‑powered operation with a dedicated charger, supporting multiple daily treatment sessions
- Simple one‑button control and clear visual cues, supplemented by step‑by‑step instructional videos
- Compatible with concurrent medication regimens, offering an adjunctive non‑drug therapy option
- Contraindicated only for users with implanted cardiac devices (e.g., pacemakers) to ensure safety
- 2‑year warranty and 2–4 day delivery for rapid patient access
- Direct‑to‑consumer sales model with optional accessory bundles (additional patches, chargers)